ZTS

ZOETIS INC.

$75.29

Current Price

All

AI analysis

Read what the AI thinks of ZOETIS INC. in the app.

Analyses are generated by AI from public data and are not investment advice.

Get the app

Key figures

Dividend per share

$1.23

Yield

1.64%

EPS

$6.08

P/E

11.4

Data as of Oct 8

Why it matters for the long term

Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Upcoming events

Quarterly earnings

Before the open · Expected EPS: $1.53

Nov 5

Posts

No posts about ZTS yet.

About ZOETIS INC.

Zoetis makes medicines, vaccines and diagnostic tests for pets and farm animals, selling to veterinarians, animal producers and retailers around the world. Its products range from arthritis and cancer treatments for dogs and cats to vaccines and health monitoring tools for cattle, pigs and poultry. The company was spun off from Pfizer in 2013 and is now the largest standalone animal-health business globally.